← FDA DRUG APPROVALS

FDA ANDA · ANDA020345

AMINOSYN-HF 8%

Sponsor: ICU MEDICAL INC

APPLICATION
ANDA020345
TYPE
ANDA
ORIGINAL APPROVAL
1996-04-04
LATEST ACTION
2005-09-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOSYN-HF 8%Discontinued
AMINO ACIDS 8% (8GM/100ML) · INJECTABLE · INJECTION

Approval history

2005-09-15Labeling · Supplement 8AP
1998-04-01Manufacturing (CMC) · Supplement 2 · standardAP
1997-07-29Manufacturing (CMC) · Supplement 3 · standardAP
1997-07-14Labeling · Supplement 1AP
1996-04-04Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →